INTERVIEW: Korea’s OncoVenture Nurturing Oncology Innovation

In an exclusive interview with PharmAsia News, a senior executive of South Korea's National OncoVenture, which aims to increase support for immuno-oncology R&D projects amid the global boom in this sector, calls for more government support, collaborations and co-development among domestic pharmas, biotechs and researchers to develop globally competitive cancer drugs.